Program seeks to standardize best treatment practices by working with
both prescribers and pharmacies
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--
Health, Inc. (NASDAQ: MGLN) today announced that Magellan Rx
Management, the pharmacy benefit management division of the company, has
launched a hemophilia management program in collaboration with Health
New England, a non-profit health plan serving the commercial, Medicaid
and Medicare markets. Hemophilia is a rare genetic bleeding disorder,
for which treatment is expensive and difficult to manage. The average
annual cost for patients with severe hemophilia can exceed $250,000 per
patient, and may be upward of $1 million for patients who have developed
The program is targeted to manage hemophilia utilization on both the
pharmacy and medical benefits, and aims to improve overall quality of
care while reducing unnecessary costs by:
Helping payers analyze information related to patient bleed history
and hemophilia treatment patterns.
Standardizing dispensing and optimal dose protocols to promote best
practices and improve transparency in hemophilia care.
Updating policies to encourage individualized treatment regimens based
on patient-specific metabolic factors.
"Variability in dosing of hemophilia products contributes to
increasingly high costs in the hemophilia category. Standardized dosing
protocols can significantly reduce potential over-utilization of
hemophilia drugs without compromising clinical outcomes," said Dr. Maria
Lopes, chief medical officer of Magellan Rx Management. "Transparency
and care coordination are also key to ensuring that hemophilia patients
receive best-in-class care; therefore, it is imperative that important
clinical information used to determine optimal outcomes is shared
between all stakeholders, including the prescriber, payer, patient and
This program will be led by clinical pharmacists, who will collaborate
with hemophilia treatment providers and pharmacies throughout the drug
delivery process to improve care coordination and ensure program goals
are being met. Regular communication between stakeholders to share key
clinical information and outcomes will be provided on a monthly basis.
"Variability of care and lack of transparency have been prevalent issues
for the management of hemophilia members for a long time. By working
with Magellan, we anticipate meaningful outcomes from both a quality and
a financial perspective by standardizing treatment expectations for all
stakeholders. Our goal is to ensure patients with hemophilia are
receiving the highest quality of care, while minimizing potential waste
created through excess dispensing and inappropriate dosing," said Andrew
J. Colby, R.Ph, Health New England's pharmacy director.
About Health New England: Based in Springfield, Mass., Health New
England is a non-profit health plan serving members in Massachusetts and
Connecticut. A wholly-owned subsidiary of Baystate Health, Health New
England offers a range of health care plans in the commercial, Medicaid
and Medicare markets. For more information, visit healthnewengland.org.
About Magellan Rx Management: Magellan Rx Management is a
full-service PBM that expands beyond traditional core services to help
its customers and members solve complex pharmacy challenges by
connecting them to the people, technology and information they need to
make smarter healthcare decisions. Magellan Rx Management is leading the
next evolution of PBMs by using a value-driven approach that moves past
the traditional volume-focused thinking to deliver true value-driven
solutions, including targeted clinical programs, powerful member and
provider engagement strategies, advanced analytics and expert specialty
pharmacy management capabilities.
About Magellan Health: Magellan
Health, Inc. is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through technology,
while remaining focused on the critical personal relationships that are
necessary to achieve a healthy, vibrant life. Magellan's customers
include health plans and other managed care organizations, employers,
labor unions, various military and governmental agencies and third-party
administrators. For more information, visit MagellanHealth.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170801005274/en/
Magellan Health, Inc.
Joe Bogdan, 860-507-1910
Source: Magellan Health, Inc.
News Provided by Acquire Media